Alnylam to Host Tenth “RNAi Roundtable” Webcast Series
Alnylam announced the schedule for its tenth 'RNAi Roundtable' webinar series, featuring three upcoming sessions on pipeline assets ALN-6400, Zilebesiran, and ALN-HTT02. The company reiterated its 'Alnylam 2030' strategic goals, aiming to expand its clinical pipeline from over 25 programs today to more than 40 by 2030.
Key figures
- Current clinical programs
- 25
- Target clinical programs 2030
- 40
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.